Our previous study demonstrated that high chemokine (C-C motif) ligand 5 (CCL5) expression is associated with improved overall survival (OS), disease-free interval, and progression-free interval in HCC, suggesting that CCL5 could serve as a valuable biomarker for patient prognosis [6]. The gene discussed is CCL5; the disease is hepatocellular carcinoma.